Rein Therapeutics Stock Market Value
| RNTX Stock | 1.38 0.06 4.17% |
| Symbol | Rein |
Rein Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rein Therapeutics. If investors know Rein will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rein Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Rein Therapeutics is measured differently than its book value, which is the value of Rein that is recorded on the company's balance sheet. Investors also form their own opinion of Rein Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Rein Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rein Therapeutics' market value can be influenced by many factors that don't directly affect Rein Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rein Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Rein Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rein Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Rein Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Rein Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Rein Therapeutics.
| 04/23/2025 |
| 07/22/2025 |
If you would invest 0.00 in Rein Therapeutics on April 23, 2025 and sell it all today you would earn a total of 0.00 from holding Rein Therapeutics or generate 0.0% return on investment in Rein Therapeutics over 90 days. Rein Therapeutics is related to or competes with TFI International, California Engels, Ioneer, Summa Silver, United Airlines, and Comstock Mining. Rein Therapeutics is entity of United States More
Rein Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Rein Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Rein Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 25.03 | |||
| Value At Risk | (6.67) | |||
| Potential Upside | 6.21 |
Rein Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Rein Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Rein Therapeutics' standard deviation. In reality, there are many statistical measures that can use Rein Therapeutics historical prices to predict the future Rein Therapeutics' volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.21) | |||
| Total Risk Alpha | (0.84) | |||
| Treynor Ratio | (0.85) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Rein Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Rein Therapeutics Backtested Returns
Rein Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.0679, which implies the firm had a -0.0679 % return per unit of risk over the last 3 months. Rein Therapeutics exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Rein Therapeutics' Variance of 20.85, risk adjusted performance of (0.03), and Coefficient Of Variation of (2,730) to confirm the risk estimate we provide. The company holds a Beta of 0.21, which implies not very significant fluctuations relative to the market. As returns on the market increase, Rein Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Rein Therapeutics is expected to be smaller as well. At this point, Rein Therapeutics has a negative expected return of -0.31%. Please make sure to check Rein Therapeutics' rate of daily change, price action indicator, as well as the relationship between the skewness and total risk alpha , to decide if Rein Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.37 |
Poor reverse predictability
Rein Therapeutics has poor reverse predictability. Overlapping area represents the amount of predictability between Rein Therapeutics time series from 23rd of April 2025 to 7th of June 2025 and 7th of June 2025 to 22nd of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Rein Therapeutics price movement. The serial correlation of -0.37 indicates that just about 37.0% of current Rein Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.37 | |
| Spearman Rank Test | -0.46 | |
| Residual Average | 0.0 | |
| Price Variance | 0.04 |
Rein Therapeutics lagged returns against current returns
Autocorrelation, which is Rein Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Rein Therapeutics' stock expected returns. We can calculate the autocorrelation of Rein Therapeutics returns to help us make a trade decision. For example, suppose you find that Rein Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Rein Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Rein Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Rein Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Rein Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Rein Therapeutics Lagged Returns
When evaluating Rein Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Rein Therapeutics stock have on its future price. Rein Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Rein Therapeutics autocorrelation shows the relationship between Rein Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Rein Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Rein Stock Analysis
When running Rein Therapeutics' price analysis, check to measure Rein Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rein Therapeutics is operating at the current time. Most of Rein Therapeutics' value examination focuses on studying past and present price action to predict the probability of Rein Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rein Therapeutics' price. Additionally, you may evaluate how the addition of Rein Therapeutics to your portfolios can decrease your overall portfolio volatility.